| Literature DB >> 34217595 |
Rajendra Karki1, Thirumala-Devi Kanneganti2.
Abstract
Cytokine storm syndrome (CSS) has generally been described as a collection of clinical manifestations resulting from an overactivated immune system. Cytokine storms (CSs) are associated with various pathologies, as observed in infectious diseases, certain acquired or inherited immunodeficiencies and autoinflammatory diseases, or following therapeutic interventions. Despite the role of CS in tissue damage and multiorgan failure, a systematic understanding of its underlying molecular mechanisms is lacking. Recent studies demonstrate a positive feedback loop between cytokine release and cell death pathways; certain cytokines, pathogen-associated molecular patterns (PAMPs), and damage-associated molecular patterns (DAMPs), can activate inflammatory cell death, leading to further cytokine secretion. Here, we discuss recent progress in innate immunity and inflammatory cell death, providing insights into the cellular and molecular mechanisms of CSs and therapeutics that might quell ensuing life-threatening effects.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34217595 PMCID: PMC9310545 DOI: 10.1016/j.it.2021.06.001
Source DB: PubMed Journal: Trends Immunol ISSN: 1471-4906 Impact factor: 19.709